Resistin is a prognostic factor for death in type 2 diabetes-Reference-Cited by-同舟云学术

Resistin is a prognostic factor for death in type 2 diabetes

Published:2018-12-13 Issue: Volume: Page:e3098
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Kapłon‐Cieślicka Agnieszka¹,Tymińska Agata¹^ORCID,Rosiak Marek²,Ozierański Krzysztof¹,Peller Michał¹,Eyileten Ceren³,Kondracka Agnieszka⁴,Pordzik Justyna³,Mirowska‐Guzel Dagmara³,Opolski Grzegorz¹,Postuła Marek³,Filipiak Krzysztof J.¹

Affiliation:

1. 1st Chair and Department of CardiologyMedical University of Warsaw Warsaw Poland

2. Department of Cardiology and HypertensionCentral Clinical Hospital, the Ministry of the Interior and Administration Warsaw Poland

3. Center for Preclinical Research and Technology (CePT), Department of Experimental and Clinical PharmacologyMedical University of Warsaw Warsaw Poland

4. Department of Internal Diseases and EndocrinologyMedical University of Warsaw Warsaw Poland

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dmrr.3098

Reference37 articles.

1. ESC guidelines on diabetes, pre‐diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force on diabetes, pre‐diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of diabetes (EASD);Rydén L;Eur Heart J,2013

2. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & rehabilitation (EACPR);Piepoli MF;Eur Heart J,2016

3. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes;Esser N;Diabetes Res Clin Pract,2014

4. Adipokines in inflammation, insulin resistance and cardiovascular disease;Li ZY;Clin Exp Pharmacol Physiol,2011

5. Adipokines and insulin resistance;Rabe K;Mol Med,2008

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistin and In-Hospital Mortality in Patients with Acute Ischemic Stroke: A Prospective Study;Journal of Clinical Medicine;2024-08-19

2. Machine Learning and Augmented Intelligence Enables Prognosis of Type 2 Diabetes Prior to Clinical Manifestation;Current Diabetes Reviews;2024-02-01

3. Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention;Clinical Nutrition ESPEN;2023-12

4. Neurological and metabolic related pathophysiologies and treatment of comorbid diabetes with depression;CNS Neuroscience & Therapeutics;2023-11-06

5. Aging adipose tissue, insulin resistance, and type 2 diabetes;Biogerontology;2023-09-19